Associations of Clinical Characteristics With Sudden Cardiac Arrest in People With Type 2 Diabetes With and Without Cardiovascular Disease: A Longitudinal Case-Control Study Using Routine Primary Care Data

• Published in: Diabetes care Vol. 48; no. 1; pp. 125 - 135
• Main Authors: Harms, Peter P., van Dongen, Laura H., Bennis, Frank, Swart, Karin M.A., Hoogendoorn, Mark, Beulens, Joline W.J., Tan, Hanno L., Elders, Petra P.J.M., Blom, Marieke T.
• Format: Journal Article
• Language: English
• Published: United States American Diabetes Association 01.01.2025
• Subjects: Aged; Antibiotics; Antihypertensives; Antipsychotics; Cardiac arrest; Cardiovascular disease; Cardiovascular diseases; Cardiovascular Diseases - epidemiology; Cardiovascular system; Case studies; Case-Control Studies; Congestive heart failure; Coronary artery disease; Death, Sudden, Cardiac - epidemiology; Diabetes; Diabetes mellitus (non-insulin dependent); Diabetes Mellitus, Type 2 - complications; Diabetes Mellitus, Type 2 - drug therapy; Diabetes Mellitus, Type 2 - epidemiology; Disease control; Drugs; Electronic health records; Fasting; Female; Glucose; Health care; Heart diseases; Heart failure; Humans; Insulin; Laboratory testing; Longitudinal Studies; Male; Middle Aged; Multivariable control; Primary care; Primary Health Care - statistics & numerical data; Psychotropic drugs; Resuscitation; Statistical analysis; Subgroups
• ISSN: 0149-5992; 1935-5548; 1935-5548
• DOI: 10.2337/dc24-0715

To assess longitudinal associations with sudden cardiac arrest (SCA) of clinical characteristics recorded in primary care in people with type 2 diabetes (T2D), both with and without cardiovascular disease (CVD). We performed a case-control study, with SCA case subjects with T2D from the Amsterdam Resuscitation Studies (ARREST) registry of out-of-hospital resuscitation attempts in the Dutch Noord-Holland region (2010-2020) and up to five matched (age, sex, T2D, general practitioner [GP] practice) non-SCA control subjects. We collected relevant clinical measurements, medication use, and medical history from GPs' electronic health care records. We analyzed the associations of clinical characteristics and medication use with SCA in the total sample and in subgroups with or without CVD using multivariable time-dependent Cox regression (hazard ratios, 95% confidence intervals). We included 689 SCA case subjects and 3,230 non-SCA control subjects. In multivariable models, low fasting glucose (<4.5 mmol/mol: 1.91 [1.00-3.64]), antihypertensive (1.80 [1.39-2.33]), glucose lowering (oral only: 1.32 [1.06-1.63]; insulin only: 2.31 [1.71-3.12]; oral and insulin: 1.64 [1.21-2.22]), heart failure (1.91 [1.55-2.35]), and QTc-prolonging prokinetic (1.78 [1.27-2.50]), antibiotic (1.35 [1.05-1.73]), and antipsychotic (2.10 [1.42-3.09]) medication were associated with SCA in the total sample. In subgroup effect modification analyses, QTc-prolonging antibiotic (1.82 [1.26-2.63]) and antipsychotic (3.10 [2.09-4.59]) medication use were associated with SCA only in those without CVD. In people with T2D, low fasting glucose and QTc-prolonging prokinetic, antibiotic, or antipsychotic medication use and a history of heart failure are associated with SCA risk. Subgroup analyses indicate antibiotic and antipsychotic medication use increases SCA risk specifically in those without CVD.